MetLife stock (US59156R1086): Morgan Stanley lifts target to $93

MetLife shares drew fresh attention after Morgan Stanley raised its price target to $93 on May 21, 2026, while the stock also touched a 52-week high this week.

MetLife shares are back in focus after Morgan Stanley raised its target to $93 and kept an Overweight rating on May 21, 2026, according to TipRanks as of 05/21/2026. The stock also hit a new 52-week high at $83.85, highlighting renewed interest in a life-insurance name with exposure to U.S. retirement and protection products.

As of 22.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: MetLife Inc.
• Sector/industry: Insurance, life and retirement
• Headquarters/country: United States
• Core markets: U.S. group benefits, retirement, Asia, Latin America
• Home exchange/listing venue: NYSE (MET)
• Trading currency: USD

MetLife Inc.: core business model

MetLife is a global insurer centered on life insurance, annuities, employee benefits, and retirement-related products. For U.S. investors, the company matters because its results can reflect consumer demand for protection products, employer-sponsored benefits, and capital-market conditions that affect insurers’ investment income.

The company’s earnings power is shaped by premium growth, policy renewals, claim trends, and the performance of its investment portfolio. That mix can make the stock more sensitive to interest-rate expectations than many investors assume, since insurers often benefit when investment yields improve and when liability assumptions remain stable.

Main revenue and product drivers for MetLife Inc.

MetLife’s main operating drivers typically include group benefits sold to employers, retirement and income solutions, and individual insurance. Those lines are important for U.S. retirement savings behavior and for corporate benefits spending, two areas that can remain resilient even when broader economic conditions soften.

The company also has business outside the United States, which can add diversification but also introduces currency and regional growth effects. For retail investors following financials on Nasdaq and the NYSE ecosystem, MetLife is a large-cap insurance name whose share performance often reflects a combination of underwriting discipline, capital management, and sentiment around rates.

Market attention rose this week after the stock reached a 52-week high of $83.85, according to Investing.com as of 05/21/2026. Around the same time, MarketBeat showed an average analyst target of $95.15 based on 14 Wall Street analysts, suggesting that recent trading strength has pushed the shares closer to published Street estimates.

Why the latest target change matters

Analyst target changes do not change fundamentals by themselves, but they can influence near-term sentiment, especially when a stock is near a technical high. Morgan Stanley’s move came with a target increase from $89 to $93, and that kind of revision often signals updated expectations for earnings durability, capital returns, or valuation support.

For U.S. investors, the key point is not the rating alone but the context around it. A large insurer with steady cash generation can draw attention when the market is reassessing defensive financials, and that can happen even without a company-specific earnings release on the same day.

The stock’s recent move also matters because insurance shares can be watched as a barometer for financial-sector stability. When a diversified insurer trades at or near a 52-week high, investors often infer that the market sees better visibility on earnings and balance-sheet strength than earlier in the year.

Conclusion

MetLife is drawing renewed investor attention after a higher Morgan Stanley target and a fresh 52-week high. The company remains a broad insurer with meaningful exposure to U.S. retirement, benefits, and capital-market conditions, which keeps it relevant for retail investors tracking financial stocks. The latest move is supportive for sentiment, but the next major catalyst will likely be the company’s own operating updates and the market’s response to them.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.